STOCK TITAN

Kiora Pharmaceuticals, Inc. (KPRX) Net Income by Year

KPRX

Kiora Pharmaceuticals, Inc. reported a net loss of $11K in fiscal year 2025. This represents a decrease of 401.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Kiora Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$11K
YoY -401.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KPRX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$11K-401.4%$4K+128.7%-$13K+99.9%-$13.6M+1.4%-$13.8M-100.7%-$6.9M+3.3%-$7.1M+34.4%-$10.8M+18.2%-$13.2M+0.9%-$13.3M-59.1%-$8.4M-440.6%-$1.6M

KPRX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-KQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$2.1M+3.4%-$2.4M-10.3%N/A$27K+100.8%-$2.2M+3.1%-$2.2M-116.3%N/A-$3.4M+40.8%-$2.2M+15.0%$13.5M+820.0%N/A-$5.8M-12.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Kiora Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Kiora Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Kiora Pharmaceuticals, Inc. reported a net loss of $11K in fiscal year 2025.

How fast is Kiora Pharmaceuticals, Inc.'s net income growing?

Kiora Pharmaceuticals, Inc. (KPRX) net income fell by 401.4% year over year, from $4K to -$11K in fiscal year 2025.

How has Kiora Pharmaceuticals, Inc.'s net income changed over the years?

Across the 12 fiscal years this page covers, Kiora Pharmaceuticals, Inc. (KPRX) net income went from -$1.6M in fiscal year 2014 to -$11K in fiscal year 2025.

Kiora Pharmaceuticals, Inc. (KPRX) reported -$2.1M in net income in Q2 2026. This represents an increase of 3.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Kiora Pharmaceuticals, Inc. (KPRX) reported on that line in every period on record.